Autism, Autism Spectrum Disorder
Conditions
Brief summary
A within-subjects design will be used for this preliminary investigation of four biomarkers across two contexts of use: prediction of treatment response (i.e., stratification) and quantification of response (i.e., change).
Detailed description
A within-subjects design will be used for this preliminary investigation of four biomarkers across two contexts of use: prediction of treatment response (i.e., stratification) and quantification of response (i.e., change). The main questions the study aims to answer are: * To evaluate the stability of each potential biomarker over a 3-4-week retest period. The biomarkers are hypothesized to have adequate stability (ICC: \> .5) in the absence of intervention. * To determine which baseline biomarker scores predict response to a manualized cognitive behavioral therapy (CBT) program for treating anxiety, Being Brave. * To determine which biomarkers are sensitive to treatment response.
Interventions
BEHAVIORALBeing Brave
Being Brave is a manualized cognitive-behavioral (CBT) intervention and includes several features that are well-aligned with the needs of autistic children: (1) an intensive parent component; (2) use of visual aids to lay out coping plans and exposure hierarchies, psychoeducation about recognizing fear and anxiety, and scripted language for coping; (3) repeated practice of well-rehearsed coping plans for novel or challenging situations; and (4) exposure exercises for social anxiety and practice of basic social skills. The intervention includes 16 weekly sessions (1 hour each). Delivery of Being Brave is flexible to allow for additional or less practice or exposure opportunities.
Sponsors
Boston Children's Hospital
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SCREENING
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
3 Years to 6 Years
Healthy volunteers
No
Inclusion criteria
* Age between 3;0 and 6;11 years old * A diagnosis of autism spectrum disorder using DSM-5 diagnostic criteria * A diagnosis of anxiety disorder using DSM-5 diagnostic criteria * Use of fluent 2-3 word phrases or fluent speech (i.e., Module 2 or 3 for ADOS-2) * Cognitive ability (either verbal or non-verbal IQ) \> 80 using the DAS-2 * A parent/guardian who is willing/able to participate and respond to interviews/surveys in English and willing/able to participate in Being Brave parent training in English and support homework activities.
Exclusion criteria
* Presence of seizures * Premature birth (\<36 weeks) or low birth weight (\<2500 gms) * Known genetic or medical disorders (e.g., Fragile X), or injuries (e.g., stroke) with implications for the nervous system or that require regular psychoactive medication that alter EEG/RSA/EDR signal (e.g., anti-convulsants) * Significant sensory or motor impairment (e.g., blindness) * Major physical abnormalities * Exposure to environmental factors that could contribute to neurocognitive delays (significant alcohol exposure in utero, extreme environmental deprivation) * Previous CBT for anxiety * Presence of conduct or oppositional defiant disorder or ADHD so severe as to interfere with the child's ability to take part in treatment * Presence of a primary presenting problem for which the intervention would be inappropriate (e.g., obsessive-compulsive disorder, severe mood disorder, suicidality) * Psychotic symptoms in the child or parents * Parent/caregiver who is not fluent in English or English is spoken in the home less than half of the time.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Spence Preschool Anxiety Scale (SPAS) or Spence Anxiety Scale (SCAS) Parent Report | At baseline enrollment visit and post intervention approximately 20 weeks later | Parents of children ages 3 to 5 will complete the SPAS and parents of 6 year old children will complete the SCAS. These are questionnaires designed to assess the severity of anxiety symptoms in preschool-aged and school-aged children. Scores range from 0-136 with higher scores indicating greater anxiety. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Behavior Assessment System for Children (BASC-3) | At baseline enrollment visit and post intervention approximately 20 weeks later | The BASC-3 measures adaptive and problem behaviors in the community and home setting. It has a strong foundation in theory and research. Scores range from 20-120 with higher scores indicating greater anxiety. |
| Pediatric Anxiety Rating Scale (PARS) | At baseline enrollment visit and post intervention approximately 20 weeks later | The PARS is a checklist which the independent evaluating clinician completes based upon parent interview. The measure is designed to assess the severity of anxiety symptoms associated with social phobia, separation anxiety disorder, and generalized anxiety disorder. Scores range from 0-25 with higher scores indicating greater anxiety. |
| Clinical Global Impression of Anxiety (CGI-A) Interview | At baseline enrollment visit and post intervention approximately 20 weeks later | The CGI-A assesses severity and improvement of anxiety using a 7-point Likert scale (from "very much better" to "very much worse"). Based on information collected from the KSADSE, PARS, and Spence, the clinician will rate the global severity of the child's global anxiety and of each individual anxiety disorder. Scores range from 0-8 with higher scores indicating greater anxiety. |
Countries
United States
Contacts
CONTACTSusan C Faja, PhD
Outcome results
None listed